Cargando…
A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
Noroviruses (NoVs) are one of the leading causes of acute gastroenteritis worldwide. NoV GII-4 VP1 protein was expressed in a recombinant baculovirus system using Sf9 insect cells. Several methods for purification and concentration of virus-like particles (VLPs) were evaluated. Electron microscopy (...
Autores principales: | Huhti, L., Blazevic, V., Nurminen, K., Koho, T., Hytönen, V. P., Vesikari, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970802/ https://www.ncbi.nlm.nih.gov/pubmed/20721592 http://dx.doi.org/10.1007/s00705-010-0768-z |
Ejemplares similares
-
Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
por: Huhti, L., et al.
Publicado: (2012) -
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
por: Tamminen, Kirsi, et al.
Publicado: (2020) -
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine
por: Blazevic, Vesna, et al.
Publicado: (2015) -
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice
por: Heinimäki, Suvi, et al.
Publicado: (2018) -
Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant
por: Tamminen, Kirsi, et al.
Publicado: (2019)